Aristea Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT03988335
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aristea Therapeutics, Inc.